These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37856951)

  • 1. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.
    Mirhashemi M; Sadeghi M; Ghazi N; Saghravanian N; Dehghani M; Aminian A
    Ann Diagn Pathol; 2023 Dec; 67():152213. PubMed ID: 37856951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of CircRNAs expression in oral squamous cell carcinoma.
    Zhang L; Wang M; Ren W; Li S; Zhi K; Gao L; Zheng J
    Oral Dis; 2023 May; 29(4):1439-1453. PubMed ID: 35286741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
    Niranjan KC; Raj M; Hallikeri K
    Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis.
    He J; Chen XF; Xu MG; Zhao J
    Arch Oral Biol; 2020 Jun; 114():104717. PubMed ID: 32344357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
    Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High CD44 Immunoexpression Correlates with Poor Overall Survival: Assessing the Role of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma Patients from the High-Risk Population of Pakistan.
    Adnan Y; Ali SMA; Farooqui HA; Kayani HA; Idrees R; Awan MS
    Int J Surg Oncol; 2022; 2022():9990489. PubMed ID: 35296132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
    Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
    BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 related stemness maneuvers oral squamous cell carcinoma biology.
    Tandon A; Singh NN; Gulati N
    Indian J Pathol Microbiol; 2022; 65(2):268-273. PubMed ID: 35435358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
    Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
    PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma.
    Lee HJ; Kang YH; Lee JS; Byun JH; Kim UK; Jang SJ; Rho GJ; Park BW
    BMC Oral Health; 2015 Dec; 15(1):153. PubMed ID: 26626427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
    Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
    Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological correlation of stem cell markers expression in oral squamous cell carcinoma; relation to patients` outcome.
    Hendawy H; Esmail AD; Zahani AMN; Elmahdi AH; Ibrahiem A
    J Immunoassay Immunochem; 2021 Nov; 42(6):571-595. PubMed ID: 33896397
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors.
    Boxberg M; Götz C; Haidari S; Dorfner C; Jesinghaus M; Drecoll E; Boskov M; Wolff KD; Weichert W; Haller B; Kolk A
    Histopathology; 2018 Oct; 73(4):559-572. PubMed ID: 29468726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of correlation between CD44, radiotherapy response, and survival rate in patients with advanced stage of head and neck squamous cell carcinoma (HNSCC).
    Dubey P; Gupta R; Mishra A; Kumar V; Bhadauria S; Bhatt MLB
    Cancer Med; 2022 May; 11(9):1937-1947. PubMed ID: 35274800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice.
    Sawant S; Gokulan R; Dongre H; Vaidya M; Chaukar D; Prabhash K; Ingle A; Joshi S; Dange P; Joshi S; Singh AK; Makani V; Sharma S; Jeyaram A; Kane S; D'Cruz A
    Clin Oral Investig; 2016 Jan; 20(1):43-56. PubMed ID: 25914047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers in stage I oral cavity squamous cell carcinoma.
    Dunkel J; Vaittinen S; Grénman R; Kinnunen I; Irjala H
    Laryngoscope; 2013 Oct; 123(10):2435-41. PubMed ID: 23918741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of Human Papilloma Virus Infection in Oral Cavity Squamous Cell Carcinoma: A Meta-Analysis.
    Christianto S; Li KY; Huang TH; Su YX
    Laryngoscope; 2022 Sep; 132(9):1760-1770. PubMed ID: 34953144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
    da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
    Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.